Updated:
Bloom Burton & Co.
Bloom Burton & Co. is a Toronto-based healthcare investment bank and principal investor founded in 2008 by Brian Bloom and Jolyon Burton.
Bloom Burton & Co.
Bloom Burton & Co. is a firm that accelerates monetization in healthcare. The firm employs a team of medical, scientific, pharmaceutical, legal, and capital markets professionals who conduct in-depth diligence. Services include capital raising, mergers and acquisitions advisory, equity research, scientific and medical consulting, direct investing, company creation, and incubation.
General information
Firm type
Asset Manager
Year founded
2008
AUM
Undisclosed
Location
Region
North America
Country
Canada
City
Toronto
Corporate office
Toronto, ON, Canada
Principals
Brian Bloom
Co-Founder, Chairman & CEO
Jolyon Burton
Co-Founder, President & Head of Investment Banking
Sector focus
Frequently asked questions
Is Bloom Burton a family office or an investment bank?
Bloom Burton operates as a dedicated healthcare investment bank. The firm provides advisory services for public offerings, private placements, and M&A, produces institutional equity research on publicly traded life sciences companies, and makes principal investments through affiliated vehicles. It is not structured as a single or multi-family office.
How does Bloom Burton differ from generalist Canadian investment banks?
Unlike the Big Five Canadian banks, which maintain healthcare as one of many sector verticals, Bloom Burton concentrates exclusively on life sciences. This sector focus allows the firm to underwrite smaller and more complex healthcare transactions that generalist desks often decline and to maintain a research team with deeper clinical and regulatory expertise.
Does the firm invest its own capital alongside clients?
Yes. Bloom Burton deploys proprietary capital into select healthcare and life sciences companies, often alongside the institutional clients it advises. This principal investing activity is a core part of the firm's model, aligning its own balance sheet with the transactions it underwrites and the coverage it provides through equity research.
What is the Bloom Burton Healthcare Investor Conference?
The firm hosts an annual healthcare investor conference in Toronto that convenes publicly traded Canadian life sciences companies with institutional allocators and analysts. The conference serves as both a business development platform and a market-structure intervention, creating a dedicated venue for Canadian healthcare investment dialogue that did not exist before Bloom Burton launched it.
What sectors does Bloom Burton focus on?
The firm works exclusively within healthcare and life sciences. Its coverage spans biotechnology, pharmaceuticals, medical devices, healthcare services, and digital health. It does not cover real estate, natural resources, technology, or any sector outside the healthcare domain.
Who founded Bloom Burton and what is their background?
Brian Bloom and Jolyon Burton co-founded the firm in 2008. Bloom serves as Chairman and CEO, with a background in capital markets from GMP Securities. Burton is President and Head of Investment Banking and brought institutional equity research experience to the partnership. The firm's name is a composite of both founders' surnames.
Does Bloom Burton manage external capital through public funds?
The firm's principal investments have historically been made through proprietary capital and co-investment structures rather than publicly listed funds. Bloom Burton does not disclose a total AUM figure publicly, consistent with its structure as a boutique that does not market pooled vehicles to retail investors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: